(2S,3S)-2,3-dihydroxybutanedioic acid;4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol
-
![(2S,3S)-2,3-dihydroxybutanedioic acid;4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/4b2628114eb44c8a912657ab95b33807.png "(2S,3S)-2,3-dihydroxybutanedioic acid;4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol")
(2S,3S)-2,3-dihydroxybutanedioic acid;4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol
structure -
-
CAS No:
101626-66-8
-
Formula:
C22H29NO9
-
Chemical Name:
(2S,3S)-2,3-dihydroxybutanedioic acid;4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol
-
Synonyms:
Dobucor;Dobuject;Dobutamin Fresenius;Dobutamin Hexal;Dobutamin ratiopharm;Dobutamin Solvay;Dobutamin-ratiopharm;Dobutamina Inibsa;Dobutamina Rovi;Dobutamine;Dobutamine (+)-Isomer;Dobutamine Hydrobromide;Dobutamine Hydrochloride;Dobutamine Lactobionate;Dobutamine Phosphate (1:1) Salt, (-)-Isomer;Dobutamine Tartrate;Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer;Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer;Dobutamine, (-)-Isomer;Dobutamine, Phosphate (1:1) Salt (+)-Isomer;Dobutrex;Hydrobromide, Dobutamine;Hydrochloride, Dobutamine;Lactobionate, Dobutamine;Lilly 81929;Oxiken;Posiject;Tartrate, Dobutamine;Dobutamine tartrate;dobutamine D-tartrate;Dobutamine tartrate [USAN];Dobutamine tartrate (USAN);101626-66-8;UNII-5D1IB9AI6J;LY 174008;5D1IB9AI6J;SCHEMBL121532;DTXSID30873946;1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (- )-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt);D03881;Q27261852;(+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol D-tartrate (1:1) (salt);1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
-
CAS No:
Description
Dobutamine Tartrate is the tartrate salt form of dobutamine, a synthetic catecholamine with sympathomimetic activity. Dobutamine primarily binds to and stimulates beta-1-adrenergic receptors located in the myocardium. As a result, it leads to a positive inotropic effect and increases in cardiac output.|A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
(2S,3S)-2,3-dihydroxybutanedioic acid;4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol Basic Attributes
451.5 g/mol
451.18423150 g/mol
C65452
Drug Information
Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)|Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)|Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Dobucor
Computed Properties
Molecular Weight:451.5
Hydrogen Bond Donor Count:8
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:10
Exact Mass:451.18423150
Monoisotopic Mass:451.18423150
Topological Polar Surface Area:188
Heavy Atom Count:32
Complexity:439
Defined Atom Stereocenter Count:2
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Request for Quotation